Purchase Order 75N91024P00228
Award Date 2/6/24
Potential Completion Date 2/5/25
Potential Value $47K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15251, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a Firm Fixed Price Delivery Order contract to Metabolon, Inc., a self-certified small disadvantaged business and for-profit organization, to provide metabolomics analysis services for a nested case-control study of lipidomics and pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study...
- The National Cancer Institute awarded a $146,900.04 firm fixed-price purchase order contract to Metabolon, Inc., a self-certified small disadvantaged business, to provide services to measure metabolomics markers related to pancreatic cancer in human serum samples. The contract has a completion date of January 31, 2017 and was not set aside. Metabolon, Inc. is a leading provider of metabolomics solutions and has served as both a prime contractor and subcontractor on numerous federal contracts and...
- The Department of Health and Human Services, National Cancer Institute awarded a $177,500.00 firm fixed price purchase order contract to Metabolon, Inc., a self-certified small disadvantaged business, for metabolomic research and serum sample analysis in pancreatic cancer. The contract has an ultimate completion date of September 15, 2018 and was awarded on September 16, 2016. Metabolon is a leading provider of metabolomics solutions and has served as both a prime contractor and subcontractor on...
- This is a $374,000 firm fixed price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Metabolon, Inc., a self-certified small disadvantaged business. The contract is for laboratory testing of blood metabolite profiles to assess the risk of developing breast cancer as part of the Cancer Prevention Study II. No set-aside was used for this award. Metabolon has extensive experience providing specialized...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National...
- <p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,640 purchase order to Human Metabolome Technologies America, Inc. for testing services. The firm fixed price contract will be performed in Boston, Massachusetts over a three month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's research efforts. No subcontractors or set aside designations were identified.</p>
- This is a firm fixed-price delivery order contract awarded to Metabolon, Inc., a self-certified small disadvantaged business, by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH). The contract, valued at $12,000.00, is for a pilot study to analyze bile acid and short-chain fatty acid panels. This work supports the NCI's Metabolomic Profiling for Molecular Epidemiology Studies program, which leverages advanced metabolomics techniques to gain insights into...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $14,700 firm fixed price purchase order to Human Metabolome Technologies America, Inc. to provide laboratory and testing services, including an Omega Scan option with no additional cost. The place of performance will be in Bethesda, Maryland. The contract period of performance spans from August 1, 2023 through November 30, 2023. No subcontractors or set aside designations were...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $103,000 firm fixed price delivery order contract to Metabolon, Inc. for assessing the physiologic impact of long-term multivitamin use and metabolite stability using repeated metabolomic measures. This contract is being performed under the agency's Metabolomic Profiling for Molecular Epidemiology Studies program. As the prime contractor, Metabolon will utilize repeated metabolomic...
- <p>The National Institutes of Health National Cancer Institute awarded a $766,604 firm fixed price delivery order contract to Metabolon, Inc. for The Liver Cancer Pooling Project Gut-Liver Axis Study under the major program code of Metabolomic Profiling for Molecular Epidemiology Studies. The work will be performed in Durham, North Carolina over a one year period ending May 16, 2023. No subcontractors were identified.</p>
The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a firm fixed price purchase order valued at forty-seven thousand two hundred forty-two dollars and six cents ($47,242.06) to Metabolon, Inc. to measure metabolomic and lipidomic concentrations on fifty-eight incident pancreatic cancer cases and fifty-eight controls, along with six blinded replicate quality control samples, totaling one hundred twenty-two biological samples. Metabolon will deliver the requested metabolomics analysis services under the purchase order, which has no set aside designation and must be completed by February 5, 2025.
Generated 3/5/24, 9:07 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $47.2k | 2/5/24 |